From December 1st 2021 Australians with Acute Myeloid Leukaemia (AML) will be able to access venetoclax treatment via the pharmaceutical benefits scheme (PBS). This will reduce the cost of treatment from $88,800 to $41.30 or $6.30 for concession card holders. Approximately 1,100 Australians are diagnosed with AML each year. AML is a result of an … Continued
Congratulations to the recipients of the 2021/22 Leukemia Lymphoma Society – Snowdome Foundation – Leukaemia Foundation (LLS-SF-LF) Translational Research Program grant winners. This year the grant is awarded to a multidisciplinary research team including, Dr Lev Kats at University of Melbourne, Prof Jake Shortt at Monash University, Prof Philip Thompson at Monash University and Assistant … Continued
Maddie Riewoldt’s Vision, the Snowdome Foundation and the Gunn Family are thrilled to announce Dr Katherine Cummins as the second ever recipient of the Gunn Family Women in Haematology Fellowship. This fellowship endorses the passion of both organisations to support the advancement of women in medical research and importantly offers long-term commitment to funding, combined … Continued
September is blood cancer awareness month and this year we are asking you to get involved. The rates of blood cancer diagnosis and mortality are increasing year on year and Snowdome needs your help to find better treatments for this indiscriminate disease. We are asking you to kiss a vice goodbye for the month of … Continued
Introducing “The Bloody Good Red” wine fundraising project. This exciting project is a collaboration between the Snowdome Foundation, Calneggia Family Vineyards and Naked Wines Australia. Mike and Sally Calneggia, own Calneggia Family Vineyards in Margaret River, Western Australia. Sadly, they lost Mike’s father Jim to Multiple Myeloma and since that time the Calneggia Family has … Continued
Fifteen years ago, the father of fashion designer, Lisa Gorman was diagnosed with two forms of blood cancer – lymphoma and leukaemia. As Lisa’s father began treatment, it became evident that more funding was required for research to uncover new treatments and better ways to manage the condition. It was during this period that Lisa … Continued
Dinner of Hope 2021 Clinical trials are a pathway to hope for blood cancer patients. Trials provide access to next generation treatments when everything else has failed your body. However, clinical trials require human infrastructure that doesn’t exist in the ‘normal’ hospital setting. A clinical research fellow is required to identify trials that meet individual … Continued
Research into the treatment, known as chimeric antigen receptor T-cell therapy (CAR T-cell), shows it is more effective than current cancer treatments, but effectiveness does not imply value as far as health budgets are concerned. Australian and US blood cancer specialists reviewed the current measures of cost effectiveness and identified multiple strategies that could be … Continued
Prof Miles Prince AM was devastated when back in 2018, his patient Tom Long had to embark on a journey to Seattle USA in order to receive chimeric antigen receptor T-cell (CAR T) therapy via a clinical trial. He knew that while Australia had the clinical expertise to administer CAR T-cell therapy, we did not … Continued